Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
648 Leser
Artikel bewerten:
(2)

Enbridge: A 'Beautiful Building for Beautiful People'

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / January 2, 2024 / Enbridge:

Groundbreaking ceremony held for Boyle Street Community Services' new facility in downtown Edmonton

Artist rendering of Boyle Street Community Services' future King Thunderbird Centre in downtown Edmonton.

It will be a beautiful building for beautiful people.

Located in the heart of Edmonton, Alberta, an abandoned building will be transformed into King Thunderbird Centre, a state-of-the-art, climate-resilient facility to support people experiencing poverty and homelessness in the city's downtown core.

"When people are exhausted, when they're hungry or they're living on the streets, the design of a facility can have a significant impact on their ability to get the services they need," says Laurel McCalla, Boyle Street Community Services' director of development, who's leading the $28.5-million capital campaign.

"The intention is to create a beautiful building for beautiful people-people who are often lost, forgotten, underestimated, stigmatized," she explains.

The groundbreaking took place on Nov. 3 at the future centre's site in Edmonton, which is within Treaty 6 Territory and within the Métis homelands and Métis National of Alberta Region 4. Elder Cliff Cardinal, who serves on the capital campaign committee, led an Indigenous ceremony at the event.

The project is eight years in the making-but the need has been there for decades.

Since 1971, BSCS has delivered its social services out of makeshift locations. For more than 30 years, the organization's primary space was in an abandoned banana-ripening warehouse with no windows. It was visibly crumbling, had flood damage, and was inaccessible for the people they serve.

"We've always had to work against our infrastructure, against the deficiencies of our facilities," McCalla explains.

With the centre, BSCS will have for the first time a purpose-built space to deliver its life-changing services.

Enbridge was proud to support this BSCS capital campaign with a $500,000 Fueling Futures grant.

Through our grant programs, we seek to help create vibrant communities. BSCS's work in its new facility will make a lasting, meaningful contribution to the city and will help empower individuals, including a large number of Indigenous people.

With the head office of our Liquids Pipelines group based in Edmonton, we also see this grant as a way to show our commitment to finding solutions to complex issues in Edmonton's downtown core.

"About 75% of the people we serve downtown are Indigenous," McCalla says. "We wanted to ensure that (the centre) is a place of healing and refuge for them."

King Thunderbird Centre's design incorporates Indigenous influences, inspired by Indigenous ways of knowing and being. Architectural features, for example, pay tribute to the medicine wheel, as do the building's colours.

The centre has been planned and designed "in collaboration with our community. Not for them but with them," McCalla notes. "Our community has always been at the forefront."

View additional multimedia and more ESG storytelling from Enbridge on 3blmedia.com.

Contact Info:

Spokesperson: Enbridge
Website: https://www.3blmedia.com/profiles/enbridge
Email: info@3blmedia.com

SOURCE: Enbridge



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.